Clara Biotech hits $850K in seed funding roundup, preparing to launch first product
June 15, 2021 | Startland News Staff
An emerging biotech startup in the region is reporting a busy spring with a significant seed round already raised and key steps under way to launch its product: a solution that removes manufacturing roadblocks for breakthrough drugs.
“We’re in an exciting and growing space and currently have low regulatory hurdles in the research stage,” said Jim West, co-founder of Clara Biotech, a Lawrence-based company already buoyed by its founding team’s expertise in exosome technologies, pharmaceutical development, engineering and building life science companies.
Elevator pitch: Clara Biotech is building an exosome isolation platform that solves a huge roadblock around manufacturing that helps the entire biopharma industry make future breakthrough drugs that may not otherwise get approved. We founded Clara Biotech to help move exosomes from research to patient.
Jim West, Clara Biotech
“We’re looking for smart money investors who can help us develop our market position, scale the technology and become the platform that companies can use to get exosome therapies to the patients who need them most,” he continued, detailing Clara Biotech’s momentum in a company snapshot update.
Off the heels of announcing an undisclosed investment by Kansas City-based Fountain Innovation Fund, the startup has raised $850,000 for its seed round, West said, with additional investments from angel investors in Boston, San Francisco, India and Kansas City.
Dr. Mei He, Clara Biotech
Clara Biotech recently received a tranche of angel tax credits, still available to qualified investors, he added.
The seed round is expected to help the company debut its beta ExoRelease exosome isolation kit, as well as continue to scale, West said.
Click here to read Clara Biotech’s full snapshot update.
“We are generating revenue and launching our first product,” he said. “At a recent conference for exosome therapeutics, sample preparation quality was the major limiting factor in manufacturing and receiving FDA approval. Our groundbreaking solution resulted in a 70 percent lead conversion rate of all companies attending (which includes investment groups and competitors). We’re currently working with and growing a number of paying early customers including some major pharmaceutical players.”
Founded in 2018 at the Bioscience and Technology Business Center in Lawrence, Clara Biotech’s therapeutic applications range from personalized medicine, targeted drug delivery, immunotherapy, and orphan and rare diseases. It’s solutions are focused on early cancer detection, Alzheimer’s disease, and virus detection.
Click here to learn more about Clara Biotech and how its technology works.
This story is possible thanks to support from the Ewing Marion Kauffman Foundation, a private, nonpartisan foundation that seeks to build inclusive prosperity through a prepared workforce and entrepreneur-focused economic development. The Foundation works to change conditions, address root causes, and break down systemic barriers so that all people – regardless of race, gender, or geography – have the opportunity to achieve economic stability, mobility, and prosperity.
For more information, visit www.kauffman.org and connect with us at www.twitter.com/kauffmanfdn and www.facebook.com/kauffmanfdn.
2021 Startups to Watch
stats here
Related Posts on Startland News
This Kansas gardener is suing for the right to sell honey and fruit from her Ottawa yard
Editor’s note: The following story was published by KCUR, Kansas City’s NPR member station, and a fellow member of the KC Media Collective. Click here to read the original story or here to sign up for KCUR’s email newsletter. Ellen Finnerty dreams of beekeeping and of supplementing the income from her warehouse job by selling products from her garden. OTTAWA,…
They called her ‘Buckwheat’ as a child; Her genre-blending new film flips the script on preconceived narratives
Jamie Addison’s production company aims to expose realities not often explored in mainstream media or society, the Kansas City filmmaker said, particularly as they reveal truths that have been hidden to create misleading or outright false narratives around gender, race and social norms. “Let’s take back the power and identity and love ourselves; truly feel…
Married puppeteers had a hand in reviving iconic Mr. Rogers characters for film; now they’ve returned to KC (with their studio)
Puppeteers are often anonymous, but Spencer Lott — and his wife and business partner, Grace Townley — are stepping into the spotlight to start their own creative studio, they shared. The Lawrence-based couple — who built the puppets used in the Tom Hanks film “A Beautiful Day in the Neighborhood” about the life of TV’s…
Show-Me Honeywell: How this high-security KC tech campus became a one-day classroom for Missouri school leaders
A group of Missouri educators, counselors and administrators took a summer trip across the state to visit notable companies and learn firsthand about relevant career pathways for their students, detailed Brian Crouse. Among the behind-the-scenes looks: a rare glimpse into the work at Honeywell Federal Manufacturing & Technologies, which manages the U.S. Department of Energy’s…